Telomere Damage Assessment via γH2A.X
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Mayo Clinic in Florida, University of Queensland, University of Pittsburgh, Yale University, Mayo Clinic, University of Newcastle Australia, Newcastle University, Cedars-Sinai Medical Center, Howard Hughes Medical Institute
Variable analysis
- Sections of paraffin-embedded liver
- γH2A.X staining on telomere regions
- Sections of paraffin-embedded liver
- γH2A.X antibody purchased from Cell Signaling
- Biotinylated secondary antibody and Fluorescein Avidin DCS purchased from Vector Laboratories
- Cy-3–labeled telomere-specific (CCCTAA) peptide nucleic acid probe (Panagene, Daejeon, KR)
- DAPI counter-staining
- In-depth Z stacking with a minimum of 40 optical slices and ×63 objective
- None specified
- None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!